JEFFERY A SMISEK
CIK 1193038 · Chairman, President & CEO · last filed 2024-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$59.60M
Companies
4
Total Filings
46
Lifetime Open-Market Net
$2.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | 43,020 | $7.30 | $314.0K | $1.47M | 6 | 2024-05-24 |
| NOV | Director | 45,804 | $21.13 | $967.8K | -$596.5K | 16 | 2015-05-14 |
| UAL | Chairman, President & CEO | 490,030 | $115.52 | $56.61M | $1.64M | 21 | 2015-03-03 |
| CAL | President | 138,502 | $14.64 | $2.03M | $0 | 1 | 2008-01-08 |
Recent Filings · Page 5 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-11-21 | NOV | Buy (P) | +2,500 | $48.3K | EDGAR |
| 2008-06-02 | NOV | Buy (P) | +110 | $8.9K | EDGAR |
| 2008-05-15 | NOV | Grant (A) | +1,251 | $0 | EDGAR |
| 2008-01-08 | CAL | Mixed | — | -$3.14M | EDGAR |
| 2007-06-05 | NOV | Grant (A) | +943 | $0 | EDGAR |
| 2007-04-30 | NOV | Mixed | — | -$263.5K | EDGAR |
Showing 41–46 of 46
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.